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1. Introduction 
A major route of metabolism of carcinogenic poly- 
cyclic aromatic hydrocarbons involves the formation 
of simple epoxides. The epoxides, which arise by the 
action of microsomal monooxygenases on the hydro- 
carbon, can be converted either by the action of gluta- 
thione S-transferase into glutathione conjugates [l-3] 
or through the action of epoxide hydrolase into 
dihydrodiols [3]. Some dihydrodiols can then be 
metabolised further to form vicinal diolepoxides [4] 
that can bind covalently to nucleic acids and that are 
believed to be responsible, in some cases, for the bio- 
logical activities of the parent hydrocarbons. Although, 
for some hydrocarbons like benzolalpyrene [5], 
benz [a] anthracene [6] and 7-methylbenz [a] anthracene 
[7,8], the diol-expoxides formed by metabolism have 
been identified, relatively little attention has been paid 
so far to the further metabolism of diol-epoxides. This 
paper describes experiments designed to investigate 
the role of glutathione S-transferase in the further 
metabolism of anti-BAS,9-diol 10,l l-oxide, a metab- 
olite of BA that contributes to the covalent binding 
of this hydrocarbon to nucleic acids in mouse skin 
[6,9], hamster embryo cells [6,9-l l] and rat-liver 
microsomal systems [ 121. All the evidence obtained is 
consistent with the idea that glutathione transferases, 
present in rat-liver supernatant, can catalyse the con- 
version of an ti-BA-8,9-diol IO,1 1 -oxide into a gluta- 
thione conjugate. 
Abbreviations: BA, benz[a]anthracene; BA-8,9diol, trans- 
8,9-dfiydro-8,9dihydroxybenz[a]anthracene; anti-8,9diol 
10,l l-oxide, r-8, t-9dihydroxy+lO,l -oxy-8,9,10,1 I-tetra- 
hydrobenz[a]anthracene; a ti-BP-7,8diol g,lO-oxide, r-7, 
t-8dihydroxy-t-9,10~xy-7,8,9,10-tetrahydrobenzo[a]pyrene; 
BA-8,9,10,11-tetrol, 8,9,10,1 I-tetrahydro-8,9,10,1l-tetra- 
hydroxybenz[a]anthracene 
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2. Materials and methods 
2.1. Materials 
I,-[gZ’cir~e-2-~H]Glutathione was purchased from 
New England Nuclear Chemicals GmbH, FRG. Anti- 
BA-8,9diol 10,l l-oxide [13] and BA-S,9,10,1 l- 
tetrol [ 1 l] were synthesised as described. Glutathione 
was obtained from Sigma Chemical Co., St Louis, MO. 
2.2. Preparation of rat-liver supematan t 
A 100 000 X gav rat-liver supernatant was piepared 
from livers (20 g) from rats that had been pretreated 
with 3-methylcholanthrene 171. A 20% (w/v) homog- 
enate prepared in phosphate buffer (0.1 M, pH 7.4) 
was centrifuged at 2000 X gav for 10 min at 4’C. The 
supernatant was then centrifuged at 100 000 X gav 
for 2 h at 4°C. A portion of the clear supematant was 
removed from between the upper fat layer and the 
pellet and was dialysed against 100 vol. distilled water 
at 0°C for 24 h. 
2.3. The preparation of glutathione conjugates 
Standard reaction mixtures (30 ml) contained anti- 
BA8Qdiol 10,l l-oxide (1 mg), dialysed rat-liver 
supernatant (3 ml) and either non-labelled glutathione 
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(9 mg) or [3H]glutathione (9 mg, 0.17 mCi/mmol) in 
phosphate buffer (50 mM, pH 7.4). Reaction mixtures 
were incubated at 37°C for 1 h and then extracted 
sequentially with ethyl acetate (2 X 2 vol.) and with 
diethyl ether (4 X 1 vol.). The aqueous phase was 
poured into ethanol (5 vol.) and the mixture heated 
to boiling point and then cooled. Precipitated pro- 
tein was removed by filtration and the crude mixture 
of water-soluble materials was evaporated to dryness 
under reduced pressure. 
The residue was redissolved in water (2 ml) and 
applied to the top of a Sephadex G-25 column (100 X 
1.5 cm) and the column eluted with water (100 ml/h). 
Fractions (65 drops) were collected and the AZ0 of 
the eluted fractions was examined. Fractions contain- 
ing W-absorbing material were pooled and evaporated 
to dryness. The residue was dissolved in water (1 ml) 
and subjected to high-pressure liquid chromatography 
(HPLC) on Spherisorb 5 ODS. The column was eluted 
at a flow rate of 2 ml/mm with water for 5 mm and 
then with a linear gradient of methanol in water 
(O-60%) for 48 min. Fractions (2 ml) were collected 
and examined for the presence of UV-absorbing 
material of W-absorbing material and, when appro- 
priate, for the presence of radioactive material using 
liquid scintillation counting. 
2.4. Amino acid analysis 
Samples for analysis were hydrolysed in 6 M HCl 
(0.5 ml) at 100°C for 24 h and amino acids present in 
the hydrolysates were separated and detected using a 
Rank-Hilger Chromospek V180 ammo acid analyser. 
Under these conditions of hydrolysis, glutamic acid 
and glycine are recovered intact whilst cysteine is 
recovered as cysteic acid. 
3. Results and discussion 
The metabolism of anti-BA8,9-diol 10,l l-oxide to 
form glutathione conjugates was investigated in exper- 
iments in which the diolepoxide was incubated with 
glutathione and a rat-liver supematant. The mixture 
was extracted with ethyl acetate and diethyl ether 
and the water-soluble material was first purified by 
chromatography on Sephadex G-25 and then subjected 
to HPLC on Spherisorb 5 ODS. Under the conditions 
used for HPLC, unreacted glutathione was recovered 
in eluted fractions 2-5 (flg.l), a major water-soluble 
metabolite was present in fractions 13-15 (product I, 
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Fig.1. High-pressure liquid chromatography of water-soluble 
material. Water-soluble materials prepared from incubations 
of anti-BA-8,9diol 10,l l-oxide with L-[gZycine-2-3H]gluta- 
thione and 100 000 X g,, rat-liver supernatant were first 
purified by chromatography on Sephadex G-25 columns, 
then subjected to HPLC on Spherisorb 5 ODS columns. The 
Spherisorb 5 ODS columns were eluted with water-methanol 
gradients as in the text and (A) radioactivity (dpm X10m4/ 
fraction, histogram) and (B) UVA,6, (e-e) determined. 
fig.lB) and a small quantity of BA-8,9,10,11-tetrol, a 
hydrolysis product of anti-BA-8,9diol IO,1 l-oxide, 
was present in fractions 5 l-52 (tig.lB). 
Evidence that the major water-soluble metabolite 
(product I, fig.lB) is a glutathione conjugate is pres- 
ented in fig.1 and in table 1. The results presented in 
table 1 (expt. 1) show that the formation of product I 
is completely dependent upon the presence of gluta- 
thione whilst those presented in fig.1 show that when 
[3H]glutathione is used, radioactive material elutes 
from the Spherisorb 5 ODS column in exactly the 
same position as product I (tig.1). Additional evi- 
dence that product I is a glutathione conjugate was 
obtained by subjecting an acid hydrolysate of product 
I to amino acid analysis. The results showed that this 
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Table 1 
Conversion of anti-BA-8,9diol lo,1 l-oxide into a glutathione 
conjugate 
- 
Expt . Incubation aConjugate 
mixture formed &g) 
_ 
1 bComplete 162 
No glutatione 0 
2 bComplete 120 
No rat-liver supernatant 26 
3 bComplete 216 
Heatdenatured rat-liver 28 
supernatant 
~_ - 
a The amount of glutathione conjugate formed was calculated 
from the total amount of UV-absorbing material present in 
fractions 13- 15 (fig.1 B), after the water-soluble metabolites 
had been subjected to HPLC on Spherisorb 5 ODS, assuming 
that the extinction coefficient (260 nm) and relative molec- 
ular mass of the conjugate were 60 000 and 582, respec- 
tively 
b The complete incubation mixture contained glutathione, 
rat-liver supernatant and anti-BA-8,9diol 10,l l-oxide (see 
text) 
product contains the 3 amino acids that comprise glu- 
tathione: namely glutamic acid, glycine and cysteine. 
Examination of the UV spectrum of the glutathione 
conjugate provides additional information about its 
structure. The UV spectrum (fig2A) is almost iden- 
tical to those of an&BA-8,9-diol 10,l l-oxide and BA- 
8,9,10,11-tetrol (fig.2B) but with small shifts in the 
maxima of the spectrum to longer wavelengths, which 
may be due to an interaction between the glutathione 
and hydrocarbon moieties in the conjugate. These 
observations indicate that, like the diol-epoxide and 
the tetrol, the conjugate possesses an intact phenan- 
threne aromatic system and are consistent with a 
mechanism for glutathione conjugate formation in 
which the sulphydryl group of glutathione reacts with 
a carbonium ion formed at either the C-10 or C-l 1 of 
the diol-epoxide. 
Evidence for the involvement of glutathioneS-trans- I 
ferase in the conversion of anti-BA-8,9-diol 10,l l- 
oxide into its glutathione conjugate was obtained by 
determining the amounts of glutathione conjugates 
formed in the presence and in the absence of a rat- 
liver supernatant. When 1 mg diol-epoxide was incub- 
ated with glutathione and rat-liver supematant, 120- 
276 pg conjugate was formed (table 1). However, 
when heat-denatured rat-liver supernatant was used or 
when the rat-liver supernatant was omitted from the 
incubation mixture the yield of conjugate was con- 
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Fig.2. UV absorption spectra measured in water of (A) the 
glutathione conjugate formed by the further metabolism of 
rmti-BA-8,9diol lO,ll-oxide (product I, fig.lB) and of(B) 
anti-BA-8,9diol lO,ll-oxide (1) and BA-8,9,10,11-tetrol (2). 
siderably less (<30 ng) (table 1). Some glutathione 
conjugate was formed, even in the absence of enzyme, 
however, an observation that is characteristic of many 
reactions that are catalysed by glutathione S-trans- 
ferases since the second substrates are usually electro- 
philic. 
A glutathione conjugate similar to that described 
in this study is also formed when BA-8,9-dial, a 
major metabolite of BA, is incubated with rat-liver 
homogenates [ 141. This conversion most probably 
occurs by the metabolism of the diol to form anti- 
BA-8,9-diol lO,l l-oxide, which can then be converted 
into the glutathione conjugate. Anti-BA-8,9diol 
IO,1 l-oxide is known to be a metabolite of BA-8,9- 
diol [4,15] and the results of this study show that this 
diol-epoxide is converted by the action of glutathione 
S-transferase into a glutathione conjugate. Anti-BA- 
8,9-diol 10,l l-oxide also contributes to covalent bind- 
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ing to DNA in mouse skin and hamster embryo cells 
[ 5,8--lo]. Consequently enzymecatalysed conversions 
of this dial-epoxide into other metabolites including 
glutathione conjugates might, in part, control the 
extent of binding of BA to nucleic acids. 
As an important corollary, these results appear to 
provide the first clear evidence that a diol-epoxide, 
formed from a polycyclic aromatic hydrocarbon by 
metabolism, can act as a substrate for glutathione 
S-transferase : the possible role of glutathione trans- 
ferases in the metabolic activation of hydrocarbons 
may merit further investigation. 
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